AXRX — Amexdrug Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.34m
- $0.87m
- $9.15m
2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.69 | 9.77 | 11.5 | 12.4 | 9.15 |
Cost of Revenue | |||||
Gross Profit | 0.455 | 0.722 | 0.963 | 0.996 | 1.01 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.66 | 9.71 | 11.2 | 12.2 | 8.95 |
Operating Profit | 0.034 | 0.055 | 0.29 | 0.217 | 0.196 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.018 | 0.027 | 0.266 | 0.187 | 0.16 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.013 | 0.018 | 0.189 | 0.101 | 0.082 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.013 | 0.018 | 0.189 | 0.101 | 0.082 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.013 | 0.018 | 0.189 | 0.101 | 0.082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | 0 | 0.001 | 0.001 | 0 |
Dividends per Share |